About Us
MyeloRx is a development stage company with compounds derived from a natural product
The disease targets for the MyeloRx compounds are acute myeloid leukemia, pancreatic cancer and immune-based diseases
The MyeloRx compounds are secured by internally developed and in-licensed intellectual property